Clinical Trial

Intravenous Lidocaine, Ketamine, and Magnesium in Thoracic Surgery

Study acronym: LKM-Thorax
Completed
View on ClinicalTrials.gov →
Summary
Thoracic surgery often produces severe postoperative pain due to nerve injury and inflammation. Effective pain control is essential to reduce complications and opioid use. This prospective observational cohort study evaluated adult patients undergoing pulmonary resection by thoracotomy or video-assisted thoracoscopic surgery (VATS). The study examined whether intraoperative administration of intravenous lidocaine, ketamine, and magnesium, used as part of multimodal analgesia, was associated with reduced postoperative morphine consumption and lower early postoperative pain scores. Outcomes included 24-hour morphine use, pain intensity at 3 and 24 hours, complications, and chronic pain at 3 months. No study-directed interventions were performed; anesthetic management followed routine clinical practice.
Trial Details
NCT Number NCT07359469
Lead Sponsor Universidad Pública de Navarra
Conditions Postoperative Pain, Thoracic Surgery, Multimodal Analgesia, Opioid Consumption, Postoperative
Enrollment 118 participants
Start Date 2018-01-01
Primary Completion 2022-02-03 (estimated)
Study Completion 2022-05-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-22